Results 191 to 200 of about 199,547 (252)

Immunoinformatic-guided design of a polo-like kinase 1 (PLK1)-targeted multi-epitope vaccine with preliminary <i>in vitro</i> validation. [PDF]

Front Bioinform
Munieswaran G, Subramani NK, Rajan AP, Manickam V.   +3 more
europepmc   +1 more source

Correction: Prime-boost immunization with inactivated human adenovirus type 55 combined with an adjuvant enhances neutralizing antibody responses in mice. [PDF]

Virol J
Seo SH, Choi JA, Jung DI, Park Y, Yang E, Jung S, Kwon T, Kwon SH, Song M.   +8 more
europepmc   +1 more source

Immunoprophylactic potential against pneumonia caused by indigenous isolates of Klebsiella pneumoniae and Streptococcus pneumoniae in experimental mice. [PDF]

Sci Rep
Waqar I, Altaf I, Bashir R, Latif K, Abbasov MA.   +4 more
europepmc   +1 more source

Rotavirus mucosal immunology: insights and research priorities from an international convening in Liverpool, March 2024. [PDF]

NPJ Vaccines
Bronowski C, Mwendera CA, Kirkwood CD, Steele AD, Groome MJ, Jere KC.   +5 more
europepmc   +1 more source

Correction to "Political Ideology and HPV Vaccine Awareness: Sex Differences and Nursing Implications Using the Health Information National Trends Survey (HINTS)". [PDF]

Nurs Res Pract
europepmc   +1 more source

SARS-CoV-2 and Influenza Co-Circulation and Co-Vaccination: A Narrative Review. [PDF]

Vaccines (Basel)
Kamransarkandi M, Varyushina EA, Gorshkov AN, Stukova MA.   +3 more
europepmc   +1 more source

Dual-adjuvant mucosal vaccine leveraging mast cell and TLR9 agonists for protection against poxvirus infection.

RSC Pharm
Murphy CT, Williamson GL, Ontiveros-Padilla L, Hendricksen AT, Johnson-Weaver BT, Choi HW, Gooden DM, Kalpathy S, Lopez AM, Pena ES, Bachelder JM, Sellers RS, Abraham SN, Staats HF, Ainslie KM.   +14 more
europepmc   +1 more source

High-Dose vs Standard-Dose Influenza Vaccines in Older Adults: A Meta-Analysis.

JAMA Netw Open
Skaarup KG, Lassen MCH, Hosseini K, Johansen ND, Loiacono MM, Harris RC, Samson SI, Palmu AA, McConeghy K, Gravenstein S, Vardeny O, Claggett B, Solomon SD, Martinón-Torres F, Biering-Sørensen T.   +14 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Combination vaccines

Primary Care: Clinics in Office Practice, 2001
The biotechnology revolution has stimulated vaccine development, blessing us with new, safe, and effective vaccines, but burdening our vaccination schedule. The incorporation of multiple individual vaccines into combination vaccines can simplify vaccine administration programs and permit the inclusion of new antigens in the vaccine schedule.
K M, Edwards, M D, Decker
  +6 more sources

Combination Vaccines

International Journal of Technology Assessment in Health Care, 1994
AbstractThe availability of new vaccines for pediatric use provides an unprecedented opportunity to prevent serious infectious diseases and their associated morbidity and mortality. However, each new product entails the need for additional injections that could become so numerous as to discourage the administration of new vaccines.
R W, Ellis, R G, Douglas
openaire   +4 more sources